Researchers conducted a cross-sectional study with data from the National Ambulatory Medical Care Survey from 2006 to 2016, and the International Classification of Diseases identified ambulatory visits with a gastrointestinal diagnosis.
More than 12,000 visits with a primary gastrointestinal diagnosis were analyzed. Between 2006 and 2016, researchers found opioid prescription rates for gastrointestinal diseases increased 0.5 percent yearly. Prescription rates were highest for chronic pancreatitis and chronic liver disease visits, and 71 percent of opioid prescriptions were renewals.
Researchers concluded: “Opioid prescription rates for gastrointestinal disease visits increased from 2006 to 2016. Our findings suggest an inadequate response to the opioid epidemic by providers managing gastrointestinal conditions. Further clinical interventions are needed to limit opioid use for gastrointestinal disease.”
More articles on surgery centers:
Will Biden, Congress be friendly to ASCs and physician ownership?
7 ASC moves in Arizona
Tips to power profitability in surgery centers
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.